Skip to content
lifestyle.bossesmag.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Amneal Pharmaceuticals LLC
Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026
June 1, 2026
Amneal Reports First Quarter 2026 Financial Results
May 29, 2026
Amneal Agrees to Acquire Kashiv BioSciences to Create Global Biosimilar Leader; Reports Strong Preliminary First Quarter 2026 Financial Results and Raises FY2026 Standalone Guidance
May 26, 2026
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
May 24, 2026
Amneal Launches Bimatoprost Ophthalmic Solution, 0.01%
May 24, 2026
Amneal to Report First Quarter 2026 Results on May 1, 2026
May 24, 2026
Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month
May 24, 2026
Amneal to Participate in Upcoming Investor Conference
May 17, 2026
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
April 22, 2026
Amneal Pharmaceuticals Added to S&P SmallCap 600® Index
January 28, 2026
1
2
Next Page
→